A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and fullness,

Here are insights into Tori Spelling’s weight loss journey and how the actress toned herself down. From medications to diet and workouts, learn all she tried!

A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs Ozempic (semaglutide)

Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer greater benefits than just weight and diabetes management.

Drugs​ like Mounjaro and Ozempic, which many use for weight loss,​​ may also help patients suffering from addiction, according to a new study.

Ozempic and similar products cut opioid and alcohol abuse by up to half, according to research that adds to evidence of the hugely popular blockbuster drugs’ broad potential beyond tackling obesity and diabetes.

In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb alcohol and opioid addiction. Published in the journal Addiction, this new study saw researchers from Loyola University Chicago sift through more than 1.

The large study analyzed more 500,000 people with a history of opioid use disorder and more than 800,000 with alcohol use disorder. Results show that those who took Ozempic or a similar GLP-1 receptor agonist drug (which are approved to treat conditions such as type 2 diabetes or obesity) had a 40 percent lower chance of overdosing on opioids and a 50 percent lower risk of getting drunk compared to those who didn't take the medication.